Clinical Trial Update: Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating albumin-bound paclitaxel plus capecitabine versus capecitabine alone in paclitaxel/docetaxel-resistant advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Capecitabine (capecitabine)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN